Stephen Johnston, Ph.D.

Stephen Johnston is the head of technologies for the Center for the Development of Therapeutics (CDoT) of the Broad Institute of MIT and Harvard. He leads a team focused on identifying differentiating technologies developed across the Broad and then scaling them in partnership with the originating lab to enable widespread usage within therapeutic applications. He has previously led scientific outreach, analytical chemistry (LC-MS), high-throughput screening, compound management, laboratory automation, high-content imaging, and data informatic scientific functions within CDoT.

Having previously served as an associate director of operations within CDoT, Johnston is also currently serving as the interim director of operations for CDoT, coordinating efforts across CDoT's people, space, infrastructure, and finances, along with other operational and strategic needs.

Johnston received his B.S. in chemistry from Davidson College, followed by a Ph.D. in analytical chemistry from the University of North Carolina at Chapel Hill and an M.B.A. from the MIT Sloan School of Management. Prior to joining the Broad in 2007, he was part of a GMP analytical methods group at Schering-Plough, harmonizing chromatographic methods for approved pharmaceutical products across Schering-Plough's worldwide manufacturing sites.

Contact Stephen Johnston via email at johnston@broadinstitute.org.